BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 4104896)

  • 1. [Use of human immunoglobulin in tetanus].
    Burkhardt G; Starke G; Seifart W
    Zentralbl Chir; 1970 Feb; 95(6):180-4. PubMed ID: 4104896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiopathology and treatment of tetanus. 2].
    Benabderrahmane M
    Schweiz Rundsch Med Prax; 1973 Dec; 62(50):1545-55. PubMed ID: 4272465
    [No Abstract]   [Full Text] [Related]  

  • 3. Report of a severe case of tetanus managed with large doses of intramuscular succinylcholine.
    Curran FJ; Smith WE; Lauro S
    Anesth Analg; 1968; 47(3):218-21. PubMed ID: 4172446
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful treatment of tetanus with tetanus hyperimmune human globulin and Valium].
    Clauberg G; Schneider W; Brändle W
    Med Welt; 1967 Nov; 47():2811-3. PubMed ID: 4180498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic consequences of immunologic reactions in manifest tetanus].
    Hiotakis K; Feischl P
    Munch Med Wochenschr; 1971 Nov; 113(47):1591-5. PubMed ID: 4109151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum levels of tetanus antibodies in tetanus patients treated with tetanus antitoxin and toxoid].
    Januszkiewicz J; Galazka A; Adamczyk J; Sporzyńska Z
    Przegl Epidemiol; 1974; 28(2):149-58. PubMed ID: 4849698
    [No Abstract]   [Full Text] [Related]  

  • 7. [Human antitetanus gamma globulins].
    Herzog F; Gaiffe M; Badillet M
    Presse Med (1893); 1969 Feb; 77(6):207-8. PubMed ID: 4182144
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current status of preventive measures in tetanus].
    Eckmann L
    Langenbecks Arch Chir; 1969; 325():937-40. PubMed ID: 4190266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe tetanus following a minor injury].
    Raatikainen P; Aukee J; Jounela A
    Duodecim; 1994; 110(23-24):2231-5. PubMed ID: 8654245
    [No Abstract]   [Full Text] [Related]  

  • 10. Human tetanus antitoxin.
    Holtzman SG; Miller KD; Murphy SG; Marin AP
    N Y State J Med; 1967 Jan; 67(2):276-7. PubMed ID: 5232786
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of manifest tetanus].
    Wiemers K; Eyrich K
    Dtsch Med Wochenschr; 1967 Jun; 92(24):1113-7. PubMed ID: 4165123
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of tetanus].
    Arsić B
    Vojnosanit Pregl; 1969 Sep; 26(9):452-60. PubMed ID: 4188956
    [No Abstract]   [Full Text] [Related]  

  • 13. The prevention of tetanus - the use of human antitetanus immunoglobulin.
    Drug Ther Bull; 1975 Sep; 13(20):77-9. PubMed ID: 1183316
    [No Abstract]   [Full Text] [Related]  

  • 14. The prevention and treatment of tetanus in the burn patient.
    Sherman RT
    Surg Clin North Am; 1970 Dec; 50(6):1277-81. PubMed ID: 4098990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunological prevention of tetanus in hospitals: practical notes].
    Di Rocco P
    Ig Mod; 1970; 63(1):38-46. PubMed ID: 4098587
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adequate dosage of tetanus antitoxin and tetanus-immune human gamma globulin TIG in the treatment of tetanus].
    Ebisawa I
    Masui; 1974 May; 23(5):381-7. PubMed ID: 4137369
    [No Abstract]   [Full Text] [Related]  

  • 17. Tetanus prophylaxis in wound management ACIP vs AAP recommendations.
    Pediatrics; 1981 May; 67(5):652. PubMed ID: 7254993
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunogenicity of tetanus toxoid used in conjunction with high doses of tetanus antitoxin].
    Galazka A; Januszkiewicz J; Sporzyńska Z; Adamczyk J
    Przegl Epidemiol; 1974; 28(3):345-53. PubMed ID: 4409780
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immune protection: preparations used].
    Pontecorvo M
    Ann Sclavo; 1973; 15(5):535-9. PubMed ID: 4595829
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].
    Auerswald W; Brücke P; Kucher R; Marsoner F; Müller H; Seidl H; Steinbereithner K; Wagner E
    Wien Med Wochenschr; 1966 Mar; 116(11):229-35. PubMed ID: 4168478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.